Literature DB >> 10485976

Effects of promethazine on bone mass and on bone remodeling in ovariectomized rats: A morphometric, densitometric, and histomorphometric experimental study.

H Rico1, M Gómez, M Revilla, J González-Riola, C Seco, E R Hernández, L F Villa, J J Gervás.   

Abstract

The effect of promethazine on bone is debated. We studied the effect of promethazine on bone and the mechanism of action involved by densitometric and histomorphometric measurements in female Wistar rats (100 days old, mean weight 25 +/- 20 g). A control group of 15 rats was not manipulated. An experimental group of 15 rats were ovariectomized (OVX) at 100 days of life and fed a diet supplemented with 4.8 mg/kg promethazine hydrochloride (OVX + Prom). The group that underwent OVX and a group of 15 rats that underwent sham ovariectomy (Sham-OVX) were not treated with promethazine. After 30 days, all the rats were killed. Their femur and 5th lumbar vertebra were dissected and cleaned of soft tissue. Femoral length and vertebral height were measured with a caliper and bones were weighed on a precision balance. The bone mineral content (BMC) and bone mineral density (BMD) of the whole right femurs and 5th lumbar vertebras were measured by dual-energy X-ray absorptiometry (DXA). Trabecular bone volume (Cn-BV-TV%), trabecular number (Tb-N mm(-1)), trabecular thickness (Tb-Th microm), and trabecular separation (Tb-Sp microm) were measured in the femurs by histomorphometric study of nondecalcified bone. Our results showed that promethazine significantly inhibited postovariectomy loss of bone mass (P < 0. 0001) by significantly reducing bone resorption, as shown by the smaller trabecular spaces observed in the treated OVX rats (P < 0. 0001).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485976     DOI: 10.1007/s002239900697

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  5 in total

1.  Increased bone fracture prevalence in postmenopausal women suffering from pollen-allergy.

Authors:  Viktoria Ferencz; Szilvia Meszaros; Emoke Csupor; Edit Toth; Katalin Bors; Andras Falus; Csaba Horvath
Journal:  Osteoporos Int       Date:  2006-01-24       Impact factor: 4.507

2.  Targeted deletion of histidine decarboxylase gene in mice increases bone formation and protects against ovariectomy-induced bone loss.

Authors:  L A Fitzpatrick; E Buzas; T J Gagne; A Nagy; C Horvath; V Ferencz; A Mester; B Kari; M Ruan; A Falus; J Barsony
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

3.  Antihistamine therapy and bone mineral density: analysis in a population-based US sample.

Authors:  Mitsuyo Kinjo; Soko Setoguchi; Daniel H Solomon
Journal:  Am J Med       Date:  2008-12       Impact factor: 4.965

4.  The effect of alendronate sodium on trabecular bone structure in an osteoporotic rat model.

Authors:  Esin Tokmak Tokmak Özşahin; Burcu Çam; Fahri Dere; Mehmet Kürkçü; Cüneyt Evrüke; Roger Soames; Özkan Oğuz
Journal:  Turk J Phys Med Rehabil       Date:  2017-06-03

5.  Effects of loratadine, a histamine H1 receptor antagonist, on the skeletal system of young male rats.

Authors:  Joanna Folwarczna; Natalia Konarek; Karolina Freier; Dawid Karbowniczek; Piotr Londzin; Aleksandra Janas
Journal:  Drug Des Devel Ther       Date:  2019-09-23       Impact factor: 4.162

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.